The historical rank and industry rank for Inhalation Sciences Sweden AB's FCF Margin % or its related term are showing as below:
XSAT:ISAB'
s FCF Margin % Range Over the Past 10 Years
Min: -354.69 Med: -93.25 Max: -21.38
Current: -181.88
During the past 11 years, the highest FCF Margin % of Inhalation Sciences Sweden AB was -21.38%. The lowest was -354.69%. And the median was -93.25%.
XSAT:ISAB's FCF Margin % is ranked worse than 87.87% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.55
vs XSAT:ISAB: -181.88
Inhalation Sciences Sweden AB FCF Margin % Related Terms
Inhalation Sciences Sweden AB FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ISAB vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Inhalation Sciences Sweden AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inhalation Sciences Sweden AB FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inhalation Sciences Sweden AB's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Inhalation Sciences Sweden AB's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inhalation Sciences Sweden AB (XSAT:ISAB) has a FCF Margin % of -41.96% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Inhalation Sciences Sweden AB and its competitors. According to the industry distribution chart, Inhalation Sciences Sweden AB ranks #717 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 87.9%.
Is Inhalation Sciences Sweden AB's FCF Margin % too high?
Inhalation Sciences Sweden AB's current FCF Margin % is -41.96%. Based on the distribution chart, Inhalation Sciences Sweden AB ranks #717 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Inhalation Sciences Sweden AB has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inhalation Sciences Sweden AB's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Inhalation Sciences Sweden AB ranks #717 out of 816 companies for FCF Margin %. This places Inhalation Sciences Sweden AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Inhalation Sciences Sweden AB and its competitors. Inhalation Sciences Sweden AB's current FCF Margin % is -41.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inhalation Sciences Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Inhalation Sciences Sweden AB (XSAT:ISAB) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.39, compared to a current price of kr0.22 — trading 42.8% below its estimated fair value. The current FCF Margin % is -41.96%. Inhalation Sciences Sweden AB's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Inhalation Sciences Sweden AB (XSAT:ISAB), the current FCF Margin % is -41.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inhalation Sciences Sweden AB (XSAT:ISAB) Overvalued in 2026?
Based on GuruFocus' analysis, Inhalation Sciences Sweden AB stock appears to be undervalued.
The current stock price of kr0.22 is trading 42.8% below its estimated GF Value™ of kr0.39.
GuruFocus considers Inhalation Sciences Sweden AB to be Possible Value Trap.
Key valuation signals for XSAT:ISAB:
FCF Margin %: -41.96%
GF Value™: kr0.39 vs. price of kr0.22 (42.8% below fair value)
No single metric tells the full story. See the XSAT:ISAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inhalation Sciences Sweden AB Business Description
Inhalation Sciences Sweden AB develops and commercializes patented lab instrument for inhalation research. Its products include PreciseInhale an advanced laboratory system used to measure inhaled particles and their effect on lungs, and LaminarPace tool for drying small amounts of the drug substance.
29GF Score
Get the complete analysis for XSAT:ISAB
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ISAB has been successfully added to your 
